Test for pancreatic cancer, by trypsinogen-activating peptide test to detect activation of pancreatic trypsinogen, differentiates between malignant and benign disease

摘要

Use of an immunological test for detecting activation of pancreatically generated trypsinogen in humans (a TAP (trypsinogen-activating peptide) test), performed on a body fluid, as a test for pancreatic cancer.